These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39265563)

  • 1. Clinical Impact of Skeletal Muscle Mass and Nutritional Status in Patients with Recurrent or Advanced Gastric Cancer Treated with Nivolumab.
    Hu Q; Kudo K; Yukaya T; Hasuda H; Nakanishi R; Nakanoko T; Ando K; Ota M; Kimura Y; Koga T; Kusumoto T; Oki E; Yoshizumi T
    Oncology; 2024 Sep; ():1-9. PubMed ID: 39265563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor.
    Deng G; Zhu D; Du Z; Xue Y; Song H; Li Y
    Cancer Med; 2024 Mar; 13(6):e7110. PubMed ID: 38506237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
    Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Prognostic Nutrition Index for Advanced Gastric Cancer Patients with Peritoneal Metastases Treated Nivolumab Monotherapy.
    Lee J; Choi SH; Baek JH; Baek DW; Kim JG; Kang BW
    Chonnam Med J; 2022 Jan; 58(1):24-28. PubMed ID: 35169556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
    Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
    Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of prognostic nutritional index with muscle loss and survival in patients with ovarian cancer treated with primary debulking surgery and chemotherapy.
    Lee J; Weng CS; Chang CL; Hsu WH; Jan YT; Wu KP
    Support Care Cancer; 2023 Apr; 31(5):267. PubMed ID: 37058264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Skeletal Muscle Mass before Salvage-Line Chemotherapy Is a Poor Prognostic Factor in Patients with Refractory Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Akiyama T; Kiyozumi Y; Eto K; Yohei N; Iwagami S; Baba Y; Yoshida N; Baba H
    Digestion; 2019; 99(1):79-85. PubMed ID: 30554226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Li S; Liu Z; Ren Y; Liu J; Lv S; He P; Yang Y; Sun Y; Chang J; Luo D; Cong M
    Front Nutr; 2022; 9():900823. PubMed ID: 35923193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer.
    Sato S; Sato M; Shinohara H
    Gen Thorac Cardiovasc Surg; 2023 Jun; 71(6):354-362. PubMed ID: 36562876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Hou S; Song D; Hao R; Li L; Zhang Y; Zhu J
    Front Immunol; 2024; 15():1382417. PubMed ID: 38966640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer.
    Chan WL; Yun HB; Cheung EE; Liu M; Hou LY; Lam KO; Wong IY; Chiu WK; Law S; Kwong D
    Oncologist; 2024 Oct; 29(10):e1272-e1279. PubMed ID: 38885304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab Monotherapy.
    Watanabe H; Yamada T; Komori K; Hara K; Kano K; Takahashi K; Kumazu Y; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Inokuchi Y; Machida N; Shiozawa M; Yukawa N; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
    In Vivo; 2021; 35(1):563-569. PubMed ID: 33402510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of skeletal muscle mass in patients with recurrent gastric cancer.
    Matsunaga T; Satio H; Miyauchi W; Shishido Y; Miyatani K; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    World J Surg Oncol; 2021 Jun; 19(1):170. PubMed ID: 34116681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study.
    Feng Y; Wang L; Guo F; Zhu F; Shi J; Wang Y; Zhang Y; Chen X; Zhang L
    Heliyon; 2024 Mar; 10(5):e27282. PubMed ID: 38463845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.
    Sun H; Chen L; Huang R; Pan H; Zuo Y; Zhao R; Xue Y; Song H
    Front Nutr; 2022; 9():1038118. PubMed ID: 36438745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy.
    Jang JY; Oh D; Noh JM; Sun JM; Kim HK; Shim YM
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1167-1176. PubMed ID: 38613258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete prognostic implication of sarcopenia according to nutritional status in surgically treated patients with hypopharyngeal cancer.
    Go JY; Lee YS; Choi YJ; Kim MJ; Kwon MS; Jung YH; Choi SH; Nam SY
    World J Surg; 2024 Aug; 48(8):1892-1901. PubMed ID: 38866697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study.
    Takenaka Y; Takemoto N; Otsuka T; Nishio M; Tanida M; Fujii T; Hayashi K; Suzuki M; Mori M; Yamamoto Y; Uno A; Inohara H
    Oral Oncol; 2022 Sep; 132():106018. PubMed ID: 35835055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment.
    Zurlo V; Rosa F; Rinninella E; Pontolillo L; Beccia V; Maratta M; Tortora G; Alfieri S; Pozzo C; Strippoli A
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1575-1584. PubMed ID: 38436190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.